In the second edition of this well-known, comprehensive title on Alzheimer’s Disease, prominent Alzheimer's investigators from throughout the world provide an updated and expanded overview of therapeutics for this devastating disease. Divided into five parts, the book begins with basic research on the neurobiology of cognitive function, offering relevant information on the way the brain encodes and stores data. The second segment covers epidemiology, including the global economic burden and risk factors for developing AD. Section three, greatly expanded from the first edition, explores the full range of issues involved in clinical assessment, while sections four and five cover the transitional stage and treatment options, respectively.